Sector portfolio · VC firm · United States
Prospect Venture Partners' Biotech portfolio
Prospect Venture Partners has backed 10 Biotech startups in rounds we track, $732M between them, shown by the stage each has reached. The best-funded is Tercica.
Funding by segment
- Series B$203M4
- Series C and later$243M4
- Growth$287M2
Where they are based
- United States9$718M
United StatesFounded
Total raised
- Under $1M0
- $1M to $10M0
- $10M to $50M4
- $50M to $250M6
- $250M to $1B0
- $1B and over0
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
10 of 10 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- United States9
Startups by country, 1 country in all.
Segment by segment
Series B
4 startups · $203M raised
Lux BiosciencesLux Biosciences is a biotechnology company developing medicines for the treatment of ophthalmic diseases.United States$90M- RRejuvenonRejuvenon a biopharmaceutical company committed developing and commercializing promising compounds for treatment of oncologic diseases.United States$49M
Roxro PharmaRoxro Pharma offers ROX-888 and ROX-828, drugs developed for the treatment of pain.United States$43M- NTNora TherapeuticsNora develops therapeutics to address unmet clinical needs in reproductive medicine.United States$21M
Series C and later
4 startups · $243M raised
Complete GenomicsComplete Genomics, a life sciences company, develops and commercializes a DNA sequencing platform for human genome sequencing and analysis.United States$104M
Pathwork DiagnosticsPathwork Diagnostics develops and delivers molecular diagnostic solutions for oncology.United States$64M
SentreHEARTSentreHEART is a medical device company developing tissue closure solutions, offering physicians control over remotely delivered sutures.United States$61M- OMOpus MedicalOpus Medical designs and manufactures medical devices for use in motion management during cancer treatment.-$14M
Growth
2 startups · $287M raised
TercicaTercica, a biotechnology company, develops and commercializes therapeutics for the treatment of endocrine and metabolic diseases.United States$149M
Alvine PharmaceuticalsAlvine Pharmaceuticals is a biotechnology company developing therapeutics for autoimmune and inflammatory diseases.United States$138M
How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Prospect Venture Partners as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosRaising from investors like Prospect Venture Partners?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.